GlassScriptPhysician profile
Donald Belles
NPI 1982721064
$2,242.31
in general payments reported to CMS, 2019-2025
8 companies · $54.10 in 2025
The $54.10 reported for 2025 was less than what a typical Prosthodontics provider received nationally (typical 2025 total: $118).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,436 · 2020: $291 · 2021: $67.49 · 2022: $46.34 · 2023: $219 · 2024: $129 · 2025: $54.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $401.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $1,289.34 | 2019-2020 | |
| Nobel Biocare USA | $359.86 | 2019-2023 | Nobelactive |
| Geistlich Pharma, North America, INC. | $177.10 | 2023 | Bio-Materials, Bio-Gide |
| Southern Implants North America INC | $142.42 | 2019 | |
| Straumann USA LLC | $129.14 | 2024 | |
| Dentsply Sirona INC | $65.93 | 2020 | |
| Biohorizons Implant Systems INC. | $63.75 | 2019-2025 | Biohorizons Dental Implants |
| Solventum Corporation | $14.77 | 2025 | Filtek, 3m Espe Filtek Supreme Ultra Universal Restorative, 3m Scotchbond |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donald Belles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.